Speakers at FDA's first-ever public hearing on using cannabis-derived ingredients in products subject to its oversight asked agency officials to look back further than history of drug research with cannabinoids to earlier than the origin of its regulations as it considers its decision. "CBD is a constituent inherent in hemp which has been marketed and used at least since the Civil War," says cannabis business attorney Rob Kight.
The US Food and Drug Administration has received more than 1,100 comments and heard arguments from competing interests including drug firms, the supplement industry and the research community about whether to allow cannabis-based substances as dietary ingredients.
For its part, the agency has been clear that a potential for impact on developing drugs with cannabis-derived substances will...